Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 6/20 | 0.40 |
| ▸ | GALR3 | O60755 | 2/20 | 0.37 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8544068 | 1.00 | RORC (0.40) | RORCGALR3NR2F2TDP1KMT2A | |
| SCHEMBL8544074 | 1.00 | RORC (0.40) | RORCGALR3NR2F2TDP1KMT2A | |
| SCHEMBL8542865 | 0.94 | RORC (0.39) | RORCGALR3NR2F2TDP1KMT2A | |
| SCHEMBL8540975 | 0.94 | RORC (0.39) | RORCGALR3NR2F2TDP1KMT2A | |
| SCHEMBL9435466 | 0.80 | CCNE2 (0.47) | TDP1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8544305 | 0.79 | RAB9A (0.51) | RORCKMT2AL3MBTL1 | |
| SCHEMBL8544306 | 0.79 | RAB9A (0.51) | RORCKMT2AL3MBTL1 | |
| SCHEMBL22911317 | 0.76 | KMT2A (0.51) | RORCKMT2AL3MBTL1PDE4B | |
| SCHEMBL21519998 | 0.76 | KMT2A (0.51) | RORCKMT2AL3MBTL1PDE4B | |
| SCHEMBL3870357 | 0.76 | KMT2A (0.51) | RORCKMT2AL3MBTL1PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0646595-B1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1998-11-04 | — | — | EP | disclosed |
| EP-0646595-A1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1995-04-05 | — | — | EP | disclosed |